Benjamin J. Zeskind
PRESIDENT AND CEO at Immuneering Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Immuneering Corporation, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immuneering Corporation June 12, 2024100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Immuneering Corporation | Open-market purchase | +2,400 | $4.56 | $10,944 |
| Jul 2, 2025 | Immuneering Corporation | Open-market purchase | +7,015 | $3.53 | $24,763 |
| Jul 1, 2025 | Immuneering Corporation | Open-market purchase | +2,985 | $3.38 | $10,089 |
| Jun 18, 2025 | Immuneering Corporation | Open-market purchase | +21,000 | $2.39 | $50,190 |
| Mar 19, 2024 | Immuneering Corporation | Open-market purchase | +20,000 | $2.77 | $55,400 |
Questions about Benjamin J. Zeskind
What boards is Benjamin J. Zeskind on?
Benjamin J. Zeskind sits on the board of Immuneering Corporation.
What company is Benjamin J. Zeskind the CEO of?
Benjamin J. Zeskind is PRESIDENT AND CEO of Immuneering Corporation.
How long has Benjamin J. Zeskind served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.